Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UTS2R | Q9UKP6 | 12/20 | 0.59 |
| ▸ | BCHE | P06276 | 1/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.49 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GPR3 | P46089 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | GABRP | O00591 | 1/20 | 0.43 |
| ▸ | GABRD | O14764 | 1/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.43 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.43 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.43 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.43 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8757524 | 0.81 | PARP14 (0.55) | UTS2RALDH1A1GPR3HSD17B10PARP14 | |
| SCHEMBL3990873 | 0.76 | UTS2R (0.46) | UTS2RCYP3A4CYP2D6KCNH2GABRP | |
| SCHEMBL23416568 | 0.74 | MEN1 (0.57) | IMPDH2IMPDH1CYP3A4ALDH1A1GPR3 | |
| SCHEMBL30981590 | 0.74 | MEN1 (0.57) | IMPDH2IMPDH1CYP3A4ALDH1A1GPR3 | |
| SCHEMBL6009655 | 0.74 | BCHE (0.58) | UTS2RBCHEACHEIMPDH2IMPDH1 | |
| SCHEMBL29475607 | 0.74 | BCHE (0.58) | UTS2RBCHEACHEIMPDH2IMPDH1 | |
| SCHEMBL3881403 | 0.73 | UTS2R (0.46) | UTS2RCYP3A4CYP2D6KCNH2GABRP | |
| SCHEMBL6007652 | 0.73 | BCHE (0.61) | UTS2RBCHEACHEIMPDH2IMPDH1 | |
| SCHEMBL27973848 | 0.72 | IMPDH2 (0.49) | UTS2RBCHEACHEIMPDH2IMPDH1 | |
| SCHEMBL14023489 | 0.71 | IDO1 (0.43) | UTS2RBCHEACHECYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3415521-A1 | METAL COMPLEXES COMPRISING AZABENZIMIDAZOLE CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | UDC Ireland Limited (IE) | 2018-12-19 | — | — | EP | disclosed |
| EP-2721043-B1 | METAL COMPLEXES COMPRISING AZABENZIMIDAZOLE CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | UDC IRELAND LTD (IE) | 2018-08-29 | — | — | EP | disclosed |
| US-9315724-B2 | Metal complexes comprising azabenzimidazole carbene ligands and the use thereof in OLEDs | BASF SE (DE) | 2016-04-19 | — | — | US | disclosed |
| EP-2721043-A1 | METAL COMPLEXES COMPRISING AZABENZIMIDAZOLE CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2014-04-23 | — | — | EP | disclosed |
| CN-103732603-A | Metal complexes comprising azabenzimidazole carbene ligands and their use in OLEDs | BASF SE | 2014-04-16 | — | — | CN | disclosed |
| US-20120319050-A1 | METAL COMPLEXES COMPRISING AZABENZIMIDAZOLE CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2012-12-20 | — | — | US | disclosed |
| WO-2012172482-A1 | METAL COMPLEXES COMPRISING AZABENZIMIDAZOLE CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2012-12-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120319050-A1 | METAL COMPLEXES COMPRISING AZABENZIMIDAZOLE CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | OCIAD1, OCIAD2, OXA1L | UTS2R 4239/4885BCHE 4262/4885ACHE 1597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.